Clinical analyses further reveal a positive correlation between VEGFA expression and RBM15/IGF2BP3/YTHDF2 levels, underscoring the central role of RBM15-mediated m6A modification in VEGFA regulation and tumor angiogenesis (Xu et al., 2024). The gene discussed is IGF2BP3; the disease is neoplasm.